F-4

ETAO International Group Announced Its Digital Insurance Business Aaliance Insurance Joined Hands with Alibaba and Tencent to Expand into the City-Wide Healthcare Insurance Market

Retrieved on: 
Tuesday, November 1, 2022
Growth, The, Pharmacy, Ant Group, Mission statement, SEC, Industry, Ecosystem, Internet, Private Securities Litigation Reform Act, Insurance, Failure, Risk, CEO, Program, City, Ownership, Vi-Jon Laboratories, Cayman, Technology, U.S. Securities and Exchange Commission, Patient, Artificial intelligence, Proxy, Registration statement, Ontario Basic Income Pilot Project, Awareness, Security (finance), Acquisition, Policy, Prospectus, Tencent, China Banking and Insurance Regulatory Commission, F-4, VIE, Telehealth, Name, Pressure, EBITDA, Charles Best (medical scientist), Social Security, Register, Securities Act of 1933, File, Sale, Form, Risk management, Forward-looking statement, Health insurance, Dam, Ali Baba (disambiguation)

NEW YORK, Nov. 1, 2022 /PRNewswire/ -- ETAO International Group ("ETAO") announced that Aaliance Insurance Brokers Co., Ltd. ("Aaliance Insurance"), one of the variable interest entities with which ETAO, through its subsidiaries, has joined hands with Alibaba andTencentto expand into the city-wide healthcare insurance market.

Key Points: 
  • NEW YORK, Nov. 1, 2022 /PRNewswire/ -- ETAO International Group ("ETAO") announced that Aaliance Insurance Brokers Co., Ltd. ("Aaliance Insurance"), one of the variable interest entities with which ETAO, through its subsidiaries, has joined hands with Alibaba andTencentto expand into the city-wide healthcare insurance market.
  • With the support of the two Internet, E-Commerce and technology giants Alibaba andTencent, ETAO would scale up the city-wide healthcare insurance service inChina's market quickly.
  • We hope that in turn would speed up the development and market penetration of ETAO's integrated healthcare services for Chinese customers."
  • It is a new supplemental health insurance model jointly promoted by the Chinese government, insurance companies and third-party platforms.

HUB Security Shareholders Approve $1.28B Nasdaq SPAC Merger

Retrieved on: 
Monday, October 31, 2022
TEL, HUB, TASE, Tel Aviv Stock Exchange, Government, Xi, Private Securities Litigation Reform Act, Public expenditure, Failure, Business, U.S. Securities and Exchange Commission, Risk, Forward-looking statement, SEC, Terminology, Form, Combination company, Veteran, Prospectus, F-4, Intelligence, Company, 100,000, The Company, Acquisition, Probability, Confidentiality, Computer security, Private law, SPAC, Security (finance)

TEL AVIV, Israel, Oct. 31, 2022 /PRNewswire/ -- HUB Cyber Security (Israel) Limited (TASE: HUB), a developer of Confidential Computing cybersecurity solutions and services ("HUB" or the "Company"), announced today that on October 27, 2022, at the extraordinary general meeting called pursuant to Section 350 of the Companies Law, 1999, its shareholders and optionholders voted to approve the previously announced SPAC merger with Mount Rainier Acquisition Corp (RNER) and delisting from the Tel Aviv Stock Exchange (TASE).

Key Points: 
  • 100% of the votes cast at the extraordinary general meeting (minus abstentions) were cast in favor of the approval of the SPAC merger and delisting from the TASE.
  • The shareholders and option holders also voted to approve all other proposals presented at the meeting.
  • HUB Cyber Security (Israel) Limited ("HUB") was established in 2017 by veterans of the 8200 and 81 elite intelligence units of the Israeli Defense Forces.
  • HUB operates in over 30 countries and provides innovative cybersecurity computing appliances as well as a wide range of cybersecurity services worldwide.

Marti Reports Strong Third Quarter 2022 Financial Results

Retrieved on: 
Wednesday, October 26, 2022
Other Travel, Software, Transportation, Travel, Technology, Apps, Applications, IOT (Internet of Things), Mobile, Wireless, Registration statement, Transport, Android, Securities Act of 1933, Daou Technology Inc., Press release, IOS, Environment, Travel, Failure, Section 10 of the Canadian Charter of Rights and Freedoms, Communication, WHEN, THE, NYSE, GAAP, Investment, Depreciation, Private Securities Litigation Reform Act, Company, Regulation, Disclosure, Suite, Commute, Risk, Growth, ANY, Annual report, Register, Income, Security (finance), IOT, Technology, Intention, Net, U.S. Securities and Exchange Commission, Prospectus, Terminology, Securities Exchange Act of 1934, Regulation S-X, Trust, Traction, Sale, SEC, Oktem, Longevity, Acquisition, Exercise, F-4, Â, YTD, Form, Proxy, COVID-19, Lithium, Airline, Bookkeeping, Video game, Ridesharing company, Risk management, Bank, Audit, EBITDA

Marti Technologies Inc. (Marti or the Company), Turkeys leading mobility app, today announced its financial results for the third quarter ended September 30, 2022.

Key Points: 
  • Marti Technologies Inc. (Marti or the Company), Turkeys leading mobility app, today announced its financial results for the third quarter ended September 30, 2022.
  • We increased prices by 10% quarter over quarter parallel to the currency devaluation of the Turkish lira by 11% during the quarter.
  • These non-GAAP financial measures are not measures of financial performance in accordance with GAAP and may exclude items that are significant in understanding and assessing the Companys financial results.
  • The Company believes these non-GAAP measures of financial results provide useful information for management and investors regarding certain financial and business trends relating to the Companys financial condition and results of operations.

AUM Biosciences, a Global Biotechnology Company Developing Precision Oncology Therapeutics, Announces Plans to Become a Public Company via Merger with Mountain Crest Acquisition Corp. V

Retrieved on: 
Thursday, October 20, 2022
MSD, CFO, Merck, Therapy, Registration statement, IND, Merck & Co., Investigational New Drug, Securities Act of 1933, Board of directors, Mutation, CEO, Director, Failure, LLP, Nasdaq, Pedigree, MNK, Trk receptor, AUMB, Regulation of tobacco by the U.S. Food and Drug Administration, Agreement, AUM, Private Securities Litigation Reform Act, NEW, EIF4E, Industry, SPAC, GLOBE, Trichuris suis, Ownership, Leadership, MTOR, Orphan, Risk, Growth, Roche, Register, Research, Security (finance), DLA Piper, TRK, Board, U.S. Securities and Exchange Commission, Prospectus, Name, Sale, Cayman Islands, SEC, Patient, Partnership, Food, Acquisition, F-4, Form, File, Proxy, COVID-19, Health, Bank, Fine chemical, Pharmaceutical industry, Financial adviser, Risk management, Holding company, Greater China

The transaction is expected to provide approximately $69 million of cash held in Mountain Crests trust account, assuming no redemptions.

Key Points: 
  • The transaction is expected to provide approximately $69 million of cash held in Mountain Crests trust account, assuming no redemptions.
  • This merger allows AUM to further continue our focus on developing our scientifically differentiated portfolio.
  • AUM is a global clinical-stage oncology company focused on advancing a clinical stage pipeline of precision oncology therapeutics designed to deploy multi-faceted inhibition strategies to reverse cancer resistance.
  • Mountain Crest and AUM caution readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made.

Moolec Science Announces Filing of a Registration Statement on Form F-4 in Connection with its Proposed Business Combination with LightJump Acquisition Corp. (NASDAQ: LJAQ)

Retrieved on: 
Tuesday, October 18, 2022
Combination company, U.S. Securities and Exchange Commission, Securities Act of 1933, Communication, Risk, Registration statement, SEC, Growth, Sale, Taste, Genetic distance, Person, Annual report, Combined, Register, Food industry, Securities Exchange Act of 1934, Plant, Form 10-K, Innovation, Company, Acquisition, Industry, F-4, Form, Proxy, GLOBE, Intellectual property, Prospectus, Forward-looking statement, Form F-4, Ownership, Property management, Security (finance), Nasdaq

The Combined Company, will be led by Mr. Gastn Paladini, Chief Executive Officer and Co-Founder of Moolec Science.

Key Points: 
  • The Combined Company, will be led by Mr. Gastn Paladini, Chief Executive Officer and Co-Founder of Moolec Science.
  • Upon completion of the transaction, the Company is expected to become a public company listed on Nasdaq under the ticker symbol MLEC.
  • In addition, LightJump has entered into a backstop agreement with entities affiliated with Moolec to guarantee a minimum of $10 million at closing.
  • No offer of securities shall be made except by means of a prospectus meeting the requirements of the Securities Act.

HUB Security Files Amendment to Registration Statement for its $1.28 billion Nasdaq Listing

Retrieved on: 
Thursday, October 20, 2022
Combination company, U.S. Securities and Exchange Commission, The Company, Veteran, Risk, SEC, Government, Sale, Xi, NASDAQ, Intelligence, Register, Business, TASE, Private Securities Litigation Reform Act, Confidentiality, Probability, Company, Acquisition, F-4, SPAC, 100,000, Form, HUB, Food and Drug Administration Amendments Act of 2007, Computer security, Public expenditure, Prospectus, Forward-looking statement, Terminology, Failure, Security (finance), Nasdaq

TEL-AVIV, Israel, Oct. 20, 2022 /PRNewswire/ -- HUB Cyber Security (Israel) Limited (TASE: HUB), a developer of Confidential Computing cybersecurity solutions and services ("HUB" or the "Company"), announced today that on October 18, 2022, it submitted Amendment No. 1 to its registration statement on Form F-4 which contains a preliminary proxy statement/prospectus to the U.S. Securities and Exchange Commission (SEC), for the purpose of completing the merger with Mount Rainier Acquisition Corp, (NASDAQ: RNER), the offering of the Company's securities to the shareholders of the SPAC and the listing of the Company's securities on Nasdaq.

Key Points: 
  • Submission of Registration Statement on Form F-4 with the SEC for the upcoming SPAC merger and the listing of the company's shares for trading on Nasdaq at a pre-money value of approximately 1.28 billion US dollars.
  • TEL-AVIV, Israel, Oct. 20, 2022 /PRNewswire/ -- HUB Cyber Security (Israel) Limited (TASE: HUB), a developer of Confidential Computing cybersecurity solutions and services ("HUB" or the "Company"), announced today that on October 18, 2022, it submitted Amendment No.
  • HUB Cyber Security (Israel) Limited ("HUB") was established in 2017 by veterans of the 8200 and 81 elite intelligence units of the Israeli Defense Forces.
  • HUB operates in over 30 countries and provides innovative cybersecurity computing appliances as well as a wide range of cybersecurity services worldwide.

20Cube Logistics to Present at LD Micro Main Event XV Conference on Wednesday, October 26, 2022

Retrieved on: 
Wednesday, October 19, 2022
Supply Chain Management, Data Management, Retail, Communications, Technology, Software, Public Relations, Investor Relations, CA, Combination company, PIPE, POD, Risk, SEC, Sale, Conference, Workflow, Solution, Combined, Transaction, Business, Technology, Probability, Company, Acquisition, Industry, Marketing, F-4, Form, Patent, Proxy, Prospectus, Forward-looking statement, Failure, COVID-19, Business architecture, Management, Risk management, Nasdaq, Evo

Ltd. (20Cube), a Singapore-based software-enabled international supply chain orchestrator, will present at the LD Micro Main Event XV Conference being held at the Luxe Sunset Boulevard Hotel in Los Angeles, CA on October 25-27, 2022.

Key Points: 
  • Ltd. (20Cube), a Singapore-based software-enabled international supply chain orchestrator, will present at the LD Micro Main Event XV Conference being held at the Luxe Sunset Boulevard Hotel in Los Angeles, CA on October 25-27, 2022.
  • 20Cube was built from the ground up over the past 10 years on a disruptive software, workflow and control tower driven platform.
  • Its suite of freight forwarding, intelligent warehousing/distribution, customs and trade compliance solutions have resulted in significant savings from better container utilization, load balancing, predictability and logistics process management.
  • Pubcos ordinary shares are expected to be listed on the Nasdaq Capital Market under the symbol TCUB.

20Cube Logistics, a Software-Enabled International Supply Chain Orchestrator, Has Entered into a Business Combination Agreement with Evo Acquisition Corp. to Enable 20Cube Logistics to Go Public

Retrieved on: 
Tuesday, October 18, 2022
Technology, Trucking, Rail, Maritime, Air, Transport, Software, Logistics, Supply Chain Management, Data Management, Combination company, PIPE, POD, Risk, Kirkland & Ellis, SEC, Sale, Review, Workflow, Person, Solution, Combined, Transaction, Business, Annual report, Technology, Form 10-K, Probability, Company, Acquisition, Marketing, Industry, F-4, Form, Pub chain, Patent, Foley & Lardner, Proxy, Prospectus, Forward-looking statement, Failure, COVID-19, Business architecture, Insurance, Financial services, Security (finance), Cube, Nasdaq, Evo

Drake Star Partners acted as exclusive financial advisor and Foley & Lardner LLP acted as legal counsel to 20Cube in the Transaction.

Key Points: 
  • Drake Star Partners acted as exclusive financial advisor and Foley & Lardner LLP acted as legal counsel to 20Cube in the Transaction.
  • 20Cube was built from the ground up over the past 10 years on a disruptive software, workflow and control tower driven platform.
  • 20Cube's platform is centered around MyHubPlus, which captures data from every part of the supply chain to provide customers with unprecedented real-time visibility, alerts, exception management and reporting.
  • Evo is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

ECARX Bolsters Executive Leadership Team

Retrieved on: 
Tuesday, October 11, 2022
CFO, Transport, TE, Securities Act of 1933, Nissan Motor Australia, Geely, Failure, Solution, Montgomery Street, News, Communication, Acceleration, Person, General counsel, Leadership, Research, Marketing, Company, Industry, Global Expansion Summit, Suite, Ownership, Form F-4, Renault, Risk, Electronics, Government, Organization, Ford Motor Company, Technology, TE Connectivity, IHU, Chief executive officer, Securities Exchange Act of 1934, Prospectus, A123 Systems, AMD, U.S. Securities and Exchange Commission, Sale, Development, SEC, Original equipment manufacturer, Partnership, MD, F-4, Form, Proxy, Heart, COVID-19, Lotus, Management, Security (finance), Investment, Polestar, Aptiv

LONDON, Oct. 11, 2022 /PRNewswire/ -- ECARX Holdings, Inc. ("ECARX"), a global mobility tech company, today announced the appointments of Ramesh Narasimhan as Chief Financial Officer, Peter Cirino as Chief Operating Officer and Andrew Winterton as General Counsel.

Key Points: 
  • In May of 2022, ECARX announced its merger agreement with COVA Acquisition Corp. ("COVA") that values ECARX at $3.82 billion pro forma equity value, or pre-money equity value of $3.4 billion.
  • ECARX transforms vehicles into seamlessly integrated information, communications, and transportation devices essential for the development of connected, automated, and electrified mobility.
  • "These exceptional leaders bring decades of experience to support ECARX as we expand to serve the fast-changing automotive industry and capture share in the large, growing market for connected cars," said ECARX Chairman and Chief Executive, Ziyu Shen.
  • ECARX was founded in 2017 and has since grown to close to 2,000 team members.

NewAmsterdam Pharma Announces Initiation of Phase 2 Dose-Finding Study Evaluating Obicetrapib in Japanese Patients

Retrieved on: 
Wednesday, October 5, 2022
Science, Cardiology, Biotechnology, Research, Pharmaceutical, Health, Genetics, Clinical Trials, CETP, Frazier Healthcare Partners, COVID, COVID 19, Ascendant, Securities Act of 1933, Health, Failure, Apolipoprotein, SEC filing, Person, Private Securities Litigation Reform Act, Company, Suite, Form F-4, Moyamoya disease, Dyslipidemia, Time, Risk, Growth, Lists of diseases, Research, Annual report, Form 10-K, Probability, Union Square, Prospectus, Intellectual property, Menarini, FLAC, Cardiovascular disease, Sale, Cayman Islands, SEC, Ezetimibe, Patient, Hospital, Philosophy, Partnership, Acquisition, F-4, Form, Adult, Safety, Proxy, Pharmaceutical industry, Financial services

The placebo-controlled, double-blind, randomized, Phase 2 dose-finding study will evaluate the efficacy, safety and tolerability of obicetrapib as an adjunct to stable statin therapy in Japanese patients.

Key Points: 
  • The placebo-controlled, double-blind, randomized, Phase 2 dose-finding study will evaluate the efficacy, safety and tolerability of obicetrapib as an adjunct to stable statin therapy in Japanese patients.
  • NewAmsterdam Pharma is investigating obicetrapib, a next-generation oral, low-dose and once-daily CETP inhibitor, as the preferred LDL-C lowering therapy to be used as an adjunct to maximally tolerated statin therapy for high-risk cardiovascular disease (CVD) patients.
  • FLAC, the Company and NewAmsterdam Pharma anticipate that subsequent events and developments will cause FLACs, the Companys and NewAmsterdam Pharmas assessments to change.
  • Neither FLAC, the Company, NewAmsterdam Pharma nor any of their respective affiliates undertake any obligation to update these forward-looking statements, except as required by law.